Topic Editors
New Advancements in Innate Immunity and Cancer Immunotherapy
Topic Information
Dear Colleagues,
Cancer immunotherapy, which involves engaging and modifying the patients' immune system, has emerged as a promising treatment alternative for various cancer types. This approach has led to substantial advancements in patient outcomes compared to earlier treatment standards.
Numerous molecular targets have been identified in the field of cancer immunotherapy. One notable example is the immune checkpoint blockade, which focuses on targeting immune suppressors and has proven to be one of the most powerful anti-cancer immunotherapy strategies.
Furthermore, focusing on the innate immune systems is equally intriguing in cancer immunotherapy. Specifically, the pathways involved in cytosolic nucleic acid sensing—particularly cGAS/STING, RIG-I/MAVs, and Toll-like receptors—play a vital role in eliciting antigen-specific immune responses that combat tumors.
This Topic centers on the use of biosensors designed for targeting cancer immunotherapy, leveraging both the innate and adaptive immune systems. We outline the initiatives to examine various targets that can be harnessed to enhance the antitumor immune response. Furthermore, we explore advancements, as well as the advantages and disadvantages of employing biosensors in cancer immunotherapy, aimed at enhancing existing treatment strategies. This Topic invites original research and review articles that are relevant to these interdisciplinary themes.
Dr. Jeonghyun Ahn
Dr. Zhiwei Hu
Topic Editors
Keywords
- biosensors
- cancer immunotherapy
- cytosolic nucleic acid sensing
- innate immune systems
- adaptive immune systems
Participating Journals
| Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC | |
|---|---|---|---|---|---|---|
Biomedicines
|
3.9 | 6.8 | 2013 | 17 Days | CHF 2600 | Submit |
Cancers
|
4.4 | 8.8 | 2009 | 20.3 Days | CHF 2900 | Submit |
Immuno
|
2.5 | 3.7 | 2021 | 31.6 Days | CHF 1200 | Submit |
International Journal of Molecular Sciences
|
4.9 | 9.0 | 2000 | 20.5 Days | CHF 2900 | Submit |
Biologics
|
- | 7.2 | 2021 | 23.5 Days | CHF 1200 | Submit |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.
